HUNTER CASEY: Open Payments
NPI 1679293054 · WOODRUFF, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,252 in 48 payments from 12 companies in 2025. Trend: 2023 $1,541 · 2024 $1,189 · 2025 $1,252
Food & beverage: $1,252
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 12 | $341 |
| Otsuka America Pharmaceutical, Inc. | 11 | $202 |
| LEO Pharma Inc. | 2 | $140 |
| Gilead Sciences, Inc. | 4 | $135 |
| Novo Nordisk Inc | 1 | $125 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $74 |
| Lundbeck LLC | 3 | $60 |
| Vanda Pharmaceuticals Inc. | 3 | $50 |
| ABBVIE INC. | 3 | $47 |
| Janssen Pharmaceuticals, Inc | 3 | $46 |
Products named: INGREZZA, REXULTI, ANZUPGO, Trodelvy, Ozempic, CAPLYTA, HETLIOZ, ABILIFY MAINTENA.
Industry payments across SC — which companies pay providers there.
